Operationalise the Centre for Commercialization for Regenerative Medicine Australia
This project will see CCRM Australia accelerating the commercialization of Australian regenerative medicine technologies, therapies and related products.
CCRM will achieve this by fostering increased collaboration between industry, clinicians and academia, both locally and globally; and nurturing local regenerative medicine companies for the international market.
Outcomes: Since project completion CCRM has received additional sector partnering requests, assisted in facilitating access to research infrastructure for local industry and created an internship program focused on the commercialisation of regenerative medicine -which is accessible to Masters and PhD students from any Australian University.
| State | Victoria |
| Consortium lead | Monash University |
| Consortium members | Australian Regenerative Medicine Institute (ARMI), CCRM (Canada), Bioplatforms Australia (BPA), Cell Therapy Manufacturing CRC, ReNerve Pty Ltd, Cynata Therapeutics Ltd, Regeneus Ltd & Australian Red Cross Blood Service |
| MTPConnect grant | $340,000 |
| Industry contribution | $723,282 |
| Project duration | January 2018 - June 2020 (Finished) |
| Contact | Silvio Tiziani, Monash University - silvio.tiziani@monash.edu |
Visit CCRM Australia for more details | Twitter: ccrm_au | LinkedIn: CCRM Australia
Listen to our podcast to hear CCRM Australia CEO Silvio Tiziani talk about the project.